Gastroesophageal Reflux Disease and Barrett's Esophagus

T. Rösch

doi:10.1055/s-2000-8087

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000012.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Endoscopy 2000; 32(11): 826-835
DOI: 10.1055/s-2000-8087

DDW Report

Gastroesophageal Reflux Disease and Barrett's Esophagus

T. Rösch

Dept. of Internal Medicine II, Technical University of Munich, Munich, Germany

Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at

Abstract
Full Text
References

Permissions and Reprints

There was enormous interest in the diagnosis and treatment of gastroesophageal reflux disease (GERD) and Barrett's esophagus (BE) at this year's Digestive Diseases Week (DDW). Since this topic predominated over other areas of clinical research in gastrointestinal endoscopy, it will be given broader scope in this series of DDW reports. As usual in recent years, data have been taken from the published abstracts, to avoid confusion; exceptions are only made for some of the new endoscopic antireflux treatments.

References

1 Park C H, Lee S W, Kwon O S, et al. The effects of anti-H. pylori therapy on development of endoscopic reflux esophagitis in peptic ulcer patients. Gastrointest Endosc. 2000; 51 AB112

PubMed Google Scholar
2 Rokkas T, Ladas S D, Triandafyllo C, et al. Time trend for the appearance of esophagitis after Helicobacter pylori eradication. Gastrointest Endosc. 2000; 51 AB110

PubMed Google Scholar
3 Hayakawa T, Kaneko H, Funaki Y, et al. Gastroesophageal pathophysiological factors affecting endoscopic findings in gastroesophageal reflux disease (GERD). Gastrointest Endosc. 2000; 51 AB111

PubMed Google Scholar
4 Pandolfino J E, Kahrilas P J, DeVault K R, et al. Comparison of inter- and intra-observer consistency of esophagitis grading by expert and trainee endoscopists. Gastrointest Endosc. 2000; 51 AB112

PubMed Google Scholar
5 Earnest D, Bhattacharyyia A K, Rogriguez-Stanley S, et al. Uncomplicated chronic heartburn: are biopsies necessary during screening endoscopy?. Gastrointest Endosc. 2000; 51 AB116

PubMed Google Scholar
6 Khaddari S SE, Damon H, Paulin C, et al. Esophageal cytology by endoscopic brushing in the diagnosis of gastroesophageal reflux disease (GERD) not complicated by esophagitis. Gastrointest Endosc. 2000; 51 AB112

PubMed Google Scholar
7 Jornod P, Dorta G o, Pantoflickova D, et al. Peptic esophageal stricture: a vanishing complication of reflux esophagitis?. Gastroenterology. 2000; 118 A484

PubMed Google Scholar
8 Gardner J D, Rodriguez-Stanley S, Robinson M G. Endoscopy-negative GERD is a gastric “hypersecretory” disorder. Gastroenterology. 2000; 118 A482

PubMed Google Scholar
9 Kato T, Naiki T, Onogi N, et al. Is an esophageal dysfunction in PSS a most important contributive factor in severe reflux esophagitis?. Gastrointest Endosc. 2000; 51 AB111

PubMed Google Scholar
10 Dahshan A H, Patel H, Delaney J, et al. Gastroesophageal reflux and dental erosions in children. Gastrointest Endosc. 2000; 51 AB113

PubMed Google Scholar
11 Mahon D, Decadt B, Lowndes R, et al. Prospective randomized trial of laparoscopic Nissen fundoplication (LNF) versus maintenance proton-pump inhibition (PPI) in the treatment of gastroesophageal reflux disease (GERD) in patients under 70 years old. Gastroenterology. 2000; 118 A485

PubMed Google Scholar
12 Lundell L, Miettinen P, Myrvold H, et al. Continued (5 year) follow-up of a randomized clinical study comparing anti-reflux surgery and omeprazole in gastroesophageal reflux disease. Gastroenterology. 2000; 118 A191

PubMed Google Scholar
13 DiRe C A, Jones M P, Kahrilas P J. The economics of laparoscopic Nissen fundoplication (LNF): less drugs, same cost. Gastroenterology. 2000; 118 A210

PubMed Google Scholar
14 Spechler S, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for GERD: effects on survival. Gastroenterology. 2000; 118 A489

PubMed Google Scholar
15 Bammer T, Hinder R A, Klingler P J, et al. Five to eight year outcome of the first laparoscopic Nissen fundoplications. Gastroenterology. 2000; 118 A1061

PubMed Google Scholar
16 Bammer T, Achem S R, DeVault K R, et al. Use of acid suppressive medications after laparoscopic antireflux surgery: prevalence, clinical indications and causes. Gastroenterology. 2000; 118 A478

PubMed Google Scholar
17 Fibbe C, Strate U, Emmermann A, et al. Does preoperative esophageal dysmotility predict outcome after laparoscopic fundoplication for GERD? A randomized, prospective trial. Gastroenterology. 2000; 118 A481

PubMed Google Scholar
18 Dehn T C, Smith G, Stratford J M. Re-operation following laparoscopic fundoplication. Gastroenterology. 2000; 118 A480

PubMed Google Scholar
19 Blom D, Bowrey D J, Peters J H, et al. The myth of dysphagia after antireflux surgery: analysis of swallowing difficulty in patients with GERD. Gastroenterology. 2000; 118 A1032

PubMed Google Scholar
20 Booth M I, Stratford J M, Thompson E, et al. Laparoscopic anti-reflux surgery is an effective treatment for the acid-sensitive esophagus. Gastroenterology. 2000; 118 A478

PubMed Google Scholar
21 Fenton P, Terry M L, Galloway K D, et al. Is there a role for laparoscopic fundoplication in patients with non-erosive reflux disease (NERD)?. Gastroenterology. 2000; 118 A481

PubMed Google Scholar
22 Bell R C, Hanna P D, Brubaker S. Laparoscopic fundoplication for symptomatic but physiologic gastroesophageal reflux. Gastroenterology. 2000; 118 A1032

PubMed Google Scholar
23 Hernandez E, Bahar R, Ament M, et al. Outcome of laparoscopic Nissen fundoplication in neurologically normal children. Gastroenterology. 2000; 118 A483

PubMed Google Scholar
24 Kaminski A, Lord R V, Crookes P F, et al. Lower esophageal sphincter residual pressure is related to dysphagia or recurrent reflux after Nissen fundoplication. Gastroenterology. 2000; 118 A1034

PubMed Google Scholar
25 Heider T R, Farrell T M, Kircher S A, et al. Complete fundoplication is not associated with increased dysphagia in patients with abnormal esophageal motility. Gastroenterology. 2000; 118 A1031

PubMed Google Scholar
26 Salo J A, Rantanen T K, Makinen J, et al. What is the clinical significance of esophageal histology after antireflux surgery?. Gastroenterology. 2000; 118 A1031

PubMed Google Scholar
27 Joubran R, Wilson M A, Wo J M. Comparison between barium esophagram and upper endoscopy for the diagnostic evaluation of postfundoplication symptoms. Gastroenterology. 2000; 118 A484

PubMed Google Scholar
28 Rothstein R I, Moodie K. Depth of endoscopically placed sutures. Gastrointest Endosc. 2000; 51 AB102

PubMed Google Scholar
29 Filipi C J, Dunne D, Sweeney S, et al. Endoscopic gastroesophageal suturing: does addition of cautery aid plication persistence?. Gastrointest Endosc. 2000; 51 AB104

PubMed Google Scholar
30 Swain P, Park P O, Kjellin T, et al. Endoscopic gastroplasty for gastroesophageal reflux disease. Gastrointest Endosc. 2000; 51 AB144

PubMed Google Scholar
31 Filipi C J, Edmundowicz S A, Gostout C J, et al. Transoral endoscopic suturing for gastroesophageal reflux disease: a multicenter trial. Gastrointest Endosc. 2000; 51 AB143

PubMed Google Scholar
32 Triadafilopoulous G, Utley D S, DiBaise J, et al. Radiofrequency energy application to the gastroesophageal junction for the treatment of gastroesophageal reflux disease. Gastrointest Endosc. 2000; 51 AB223

PubMed Google Scholar
33 DiBaise J K, Akromis I, Quigley E M. Efficacy of radiofrequency energy delivery to the lower esophageal sphincter in the treatment of GERD. Gastrointest Endosc. 2000; 51 AB96

PubMed Google Scholar
34 SEER Report. National Cancer Institute's surveillance, epidemiology and end results program (public use CD-ROM). Bethesda, MD; National Cancer Institute, 1998

Google Scholar
35 Lambert R. The role of endoscopy in the prevention of digestive cancer: application to colorectal cancer. Endoscopy. 1998; 3 628-40

PubMed Google Scholar
36 Lambert R. The role of endoscopy in the prevention of esophagogastric cancer. Endoscopy. 1999; 31 180-99

Article in Thieme Connect PubMed Google Scholar
37 Eckardt V F, Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Gastrointest Endosc. 2000; 51 AB225

PubMed Google Scholar
38 Conio M, Filiberti R, Blanchi S, et al. Long-term endoscopic surveillance of patients with Barrett's esophagus: a prospective study. Gastroenterology. 2000; 118 A223

PubMed Google Scholar
39 Zaman M S, Robson K, Rosenberg S, et al. The development of dysplasia on follow-up endoscopy among patients with short-segment Barrett's esophagus: a cohort of 61 patients followed for a mean of 30 months. Gastrointest Endosc. 2000; 51 AB115

PubMed Google Scholar
40 Hillman L C, Chiragakis L, Kaye G L, et al. Significance of short-segment Barrett's esophagus. Gastroenterology. 2000; 118 A222

PubMed Google Scholar
41 Feldshon S D, Rodlund J L. Barrett's esophagus: surveillance for short- and long-segment disease. Gastrointest Endosc. 2000; 51 AB117

PubMed Google Scholar
42 Pereira A D, Chaves P, Suspiro A, et al. Incidence of high-grade dysplasia/adenocarcinoma in Barrett's esophagus: a prospective study in a low-risk country for adenocarcinoma of the esophagus. Gastroenterology. 2000; 118 A38

PubMed Google Scholar
43 Rösch T, Allescher H D. Digestive Diseases Week report, Orlando, May 1999. Endoscopy. 1999; 31 768-827

PubMed Google Scholar
44 Ott R, Rösch T, Muehlen J, et al. Much ado about the “ultrashort” Barrett esophagus? Results from the Munich multicenter study. Gastrointest Endosc. 2000; 51 AB114

PubMed Google Scholar
45 de Mas C R, Krämer M, Seifert E, et al. Short Barrett: prevalence and risk factors. Scand J Gastroenterol. 1999; 34 1065-1070

Crossref PubMed Google Scholar
46 Morales T G. The irregular Z-line in community practice: do we need to biopsy?. Gastrointest Endosc. 2000; 51 AB115

PubMed Google Scholar
47 Nandurkar S, Talley N J, Martin C J, et al. Prevalence and associations of cardia epithelium. Gastroenterology. 2000; 118 A226

PubMed Google Scholar
48 El-Zimaity H M, Verghese V J, Ramchchatesingh J, et al. The gastric cardia in gastroesophageal reflux disease. Gastroenterology. 2000; 118 A480

PubMed Google Scholar
49 Fass R, Sampliner R E, Spechler S J. The relationship between esophageal acid exposure, dysplasia and extent of columnar metaplasia in Barrett's esophagus. Gastroenterology. 2000; 118 A685

PubMed Google Scholar
50 Tharalson E F, Martinez S, Pulliam G, et al. Correlation between the height of abnormal acid reflux and the length of Barrett's esophagus. Gastroenterology. 2000; 118 A230

PubMed Google Scholar
51 Koek G H, Sifrim D, Lerut T, et al. Esophagitis and Barrett's esophagus: acid reflux, bile reflux, or both?. Gastroenterology. 2000; 118 A224

PubMed Google Scholar
52 Pfaffenbach B, Orth K H, Langer M, et al. Bile and acid reflux in short- and long-segment Barrett's esophagus, and in reflux disease. Gastroenterology. 2000; 118 A227

PubMed Google Scholar
53 Menges M, Moeller M, Zeitz M. Increased acid and bile reflux in patients with Barrett's esophagus compared with reflux esophagitis: response to acid-suppressant therapy. Gastroenterology. 2000; 118 A226

PubMed Google Scholar
54 Bohmer C J, Hop W C, Meuwissen S G, et al. Carcinoma of Barrett's esophagus: do smoking and alcohol really matter?. Gastroenterology. 2000; 118 A459

PubMed Google Scholar
55 Freedman J, Ye W, Naslund E, et al. Increased risk of adenocarcinoma of the esophagus after cholecystectomy. Gastroenterology. 2000; 118 A482

PubMed Google Scholar
56 Abe Y, Ohara S, Sekine H, et al. The effect of H. pylori infection in reflux esophagus and Barrett's esophagus. Gastroenterology. 2000; 118 A221

PubMed Google Scholar
57 Romero Y, Cameron A J, Burgart L J, et al. Barrett's esophagus: a familial disorder?. Gastroenterology. 2000; 118 A222

PubMed Google Scholar
58 Sharma P, Kalahasthy K, Topalovski M ,. Location of dysplasia and cancer in patients with Barrett's esophagus. Gastroenterology. 2000; 118 A38

PubMed Google Scholar
59 Chaves P, Pereira A D, Cruz C, et al. Recurrence of columnar-lined esophagus segments (CLES) after surgery for Barrett's-associated adenocarcinoma: the natural history of Barrett's esophagus. Gastroenterology. 2000; 118 A222

PubMed Google Scholar
60 Dresner S M, Lamb P J, Irving M, et al. Adenocarcinoma arising in Barrett's esophagus: the impact of surveillance on stage and outcome. Gastroenterology. 2000; 118 A704

PubMed Google Scholar
61 Lin O S, Mannava S, Hwang K L, et al. Screening, surveillance and treatment practices for Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB114

PubMed Google Scholar
62 Petraki K, Mantzaris G J, Petraki C, et al. Immunohistochemical expression of cytokeratins 7 and 20 in gastric intestinal metaplasia and in Barrett's esophagus. Gastroenterology. 2000; 118 A226

PubMed Google Scholar
63 Sharma P, Topalovski M, Weston A P, et al. Cytokeratin 7 and 20 staining patterns in patients with cardia intestinal metaplasia associated with either Barrett's esophagus or H. pylori. Gastroenterology. 2000; 118 A229

PubMed Google Scholar
64 Shearer C J, Going J J, MacKay C J, et al. Patterns of cytokeratin 7 and 20 expression in esophageal and gastric intestinal metaplasia: relationship to GERD. Gastroenterology. 2000; 118 A229

PubMed Google Scholar
65 Nandurkar S, Ormsby A H, Talley N J, et al. Short-segment Barrett's or not: cytokeratin (CK) 7/20 immunoreactivity could be the key. Gastroenterology. 2000; 118 A226

PubMed Google Scholar
66 Pace F, Pallotta S, Foschi D, et al. Absence of distinctive cells in the squamocolumnar junction of patients with Barrett's esophagus (BE): an ultramicroscopic study. Gastroenterology. 2000; 118 A227

PubMed Google Scholar
67 Moerk H, Scheurlen M, Al-Taie O, et al. Characterization of Barrett's and regenerative squamous mucosa by MUC1 and MUC2 mRNA expression. Gastroenterology. 2000; 118 A226

PubMed Google Scholar
68 Dutta S K, Choi Y L, Lagerholm S, et al. Evidence for enhanced expression of telomerase activity in patients with Barrett's esophagus with dysplasia and adenocarcinoma. Gastroenterology. 2000; 118 A707

PubMed Google Scholar
69 Morris C D, Bigley G, Armstrong G R, et al. Expression of cyclooxygenase-2 (COX-2) in Barrett's esophagus, dysplasia and adenocarcinoma. Gastroenterology. 2000; 118 A685

PubMed Google Scholar
70 Robert M E, Washington M K, Lee J R, et al. Diagnosis of dysplasia in Barrett's esophagus by immunohistochemistry of nuclear proliferation (P53) and cellular trafficking (RAB 11). Gastroenterology. 2000; 118 A228

PubMed Google Scholar
71 Jost C, Lewin D N, Mulcahy H E, et al. Do gastroesophageal reflux-induced changes in the squamous mucosa have a positive association with the presence of the intestinal metaplasia of Barrett's esophagus?. Gastrointest Endosc. 2000; 51 AB117

PubMed Google Scholar
72 Madsen J A, Mitros F A. Interobserver variability of Barrett esophagus related to gastrointestinal pathology training. Gastroenterology. 2000; 118 A225

PubMed Google Scholar
73 Ormsby A H, Petras R E, Henricks W H, et al. Interobserver variation in Barrett's (BE)-related high-grade dysplasia (HGD) and superficial adenocarcinoma: can it be improved using uniform pathologic criteria?. Gastroenterology. 2000; 118 A686

PubMed Google Scholar
74 Jost C, Lewin D N, Mulcahy H E, et al. Toward the development of databases on Barrett's esophagus: the variability of routine histopathological reporting on biopsies in patients with suspected Barrett's requires a systematic review for consistent data collection. Gastrointest Endosc. 2000; 51 AB116

PubMed Google Scholar
75 Buttar N S, Wang K S, Krishnadath K K, et al. Digital image analysis is highly sensitive and specific in differentiating high- from low-grade dysplasia in Barrett's esophagus. Gastroenterology. 2000; 118 A684

PubMed Google Scholar
76 Saeian K, Staff D, Townsend W, et al. Detection rate of dysplastic Barrett's mucosa by unsedated transnasal endoscopy (T-EGD) is comparable to conventional endoscopy. Gastroenterology. 2000; 118 A228

PubMed Google Scholar
77 Wo J M, Ray M B, Mayfield-Stokes S, et al. Diagnostic benefit of methylene blue-directed biopsy compared to conventional biopsy for the diagnosis of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB113

PubMed Google Scholar
78 Tonelotto E B, Torresini R S, Coelho N V, et al. Magnifying endoscopy can make the diagnosis of specialized intestinal metaplasia at the esophagogastric junction. Gastrointest Endosc. 2000; 51 AB117

PubMed Google Scholar
79 Guelrud M, Herrera I, Castro J, et al. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB91

PubMed Google Scholar
80 Sueoka N, Nisigaki H, Yonezawa M, et al. Usefulness of double dye staining (methylene blue and crystal violet) for the magnifying observation of intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB117

PubMed Google Scholar
81 Das A, Sivak J R, et al. MV, Chak A, et al. Role of high-resolution endoscopic imaging using optical coherence tomography (OCT) in patients with Barrett's esophagus (BE). Gastrointest Endosc. 2000; 51 AB93

PubMed Google Scholar
82 Poneros J M, Brand S, Bouma B E, et al. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastrointest Endosc. 2000; 51 AB226

PubMed Google Scholar
83 Seitz U. In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus, and adenocarcinoma of the esophagus. Gastrointest Endosc. 2000; 51 AB94

PubMed Google Scholar
84 Gonzalez-Correa C A, Brown B H, Smallwood R H, et al. Towards the diagnosis of Barrett's esophagus by electric virtual biopsies. Gastroenterology. 2000; 118 A223

PubMed Google Scholar
85 Egger K, Rösch T, Allescher H D, et al. Video endoscopy and stepwise biopsy of Barrett's esophagus are still necessary despite sophisticated diagnostic methods. Gastrointest Endosc. 2000; 51 AB115

PubMed Google Scholar
86 Sontag S J, Schnell T G, Chejfec G. Prevalence and incidence of ADCA in Barrett's with flat mucosa and in Barrett's with teeny-weeny bumps: don't be so cocky. Gastroenterology. 2000; 118 A720

PubMed Google Scholar
87 Gossner L, May A, Pech O, et al. Chromoendoscopy for the detection of dysplasia or mucosal cancer in Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB120

PubMed Google Scholar
88 Banerjee B, Agarwal S, Jonnalagada S, et al. Use of shorter wavelength autofluorescence band in Barrett's esophagus: effect of dysplasia and inflammation. Gastrointest Endosc. 2000; 51 AB115

PubMed Google Scholar
89 Saidi R, Wong Kee Song L M, DaCosta R, et al. Fluorescence studies of the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX in Barrett's esophagus. Gastroenterology. 2000; 118 A230

PubMed Google Scholar
90 Brand S A, Wang T D, Schomacker K T, et al. Detection of high-grade dysplasia in Barrett's esophagus by 5-aminolevulinic acid (ALA)-induced protoporphyrin IX (PPIX) fluorescence spectroscopy. Gastroenterology. 2000; 118 A193

PubMed Google Scholar
91 Jornod P, Stepinac T, Lange N, et al. Barrett's esophagus: high detection rate for dysplasia and early adenocarcinoma by combined screening with 4-quadrant biopsies and photodynamic detection. Gastroenterology. 2000; 118 A685

PubMed Google Scholar
92 Wong Kee Song L M, Shim G M, Wilson B C, et al. Identifying dysplasia within Barrett's esophagus using Raman spectroscopy. Gastrointest Endosc. 2000; 51 AB226

PubMed Google Scholar
93 Lovat L B, Pickard D, Novelli M, et al. A novel optical biopsy technique using elastic scattering spectroscopy for dysplasia and cancer in Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB227

PubMed Google Scholar
94 May A D, Pech O, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB114

PubMed Google Scholar
95 Wang K K, Buttar N S, Lutzke L S, et al. Long-term results of photodynamic therapy for Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB225

PubMed Google Scholar
96 Wolfsen H C, Woodward T A. Photodynamic therapy for dysplastic Barrett's esophagus and mucosal esophageal adenocarcinoma: the value of endoscopic ultrasound and results using the bare fiber technique. Gastrointest Endosc. 2000; 51 AB116

PubMed Google Scholar
97 Nijhawan P K, Wolfsen H, Wand K K, et al. Cutaneous photosensitivity after photodynamic therapy: is it really more common in sunny climates?. Gastroenterology. 2000; 118 A227

PubMed Google Scholar
98 Buttar N S, Nijhawan P K, Krishnadath K K, et al. Combined endoscopic mucosal resection (EMR) and photodynamic therapy (PDT) for esophageal neoplasia within Barrett's esophagus. Gastroenterology. 2000; 118 A35

PubMed Google Scholar
99 Spinelli P, Conio M, Mancini A, et al. The association of endoscopic mucosal resection and photodynamic therapy in the treatment of nodular dysplastic areas arising in Barrett's esophagus. Gastrointest Endosc. 2000; 51 AB103

PubMed Google Scholar
100 Tigges H, Fuchs K H, Maroske J, et al. Combination of endoscopic argon plasma coagulation (EACP) and antireflux surgery for treatment of Barrett's esophagus. Gastroenterology. 2000; 118 A1058

PubMed Google Scholar
101 Hafner S G, Straub T K, Wehrmann M, et al. Experimental results for a new strategy to treat Barrett's esophagus: an in-vitro study by using endoscopic high-frequency ultrasound. Gastrointest Endosc. 2000; 51 AB113

PubMed Google Scholar

T. Rösch,M.D.

Dept. of Internal Medicine II Klinikum rechts der Isar Technical University of Munich

Ismaninger Strasse 22 81675 München Germany

Fax: Fax:+ 49-89-4140-4872 or + 49-89-4141-9245

Email: E-mail:Thomas.Roesch@lrz.tu-muenchen.de

>